Cell Line Development

At Samsung Biologics, we understand the importance of optimal cell line development in successfully navigating clinical trials and challenging regulatory approval processes. Our deep expertise and commitment to excellence help you reduce time to the market and keep costs low while achieving the best possible outcomes for your journey.
High-performing CHO-based cell line development platform

S-CHOice® builds on glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line technology and shows improved titers for standard monoclonal antibodies. The cell line also shows enhanced viability in a fed-batch study.

  • An upgraded S-CHOice® cell line to produce enhanced ADCC* activity antibodies
    *ADCC: Antibody Dependant Cellular Cytotoxidity

Cell Line Development Workflow

Samsung Biologics’ Cell Line Development service offers clients a cell line process that combines world-class technology, a strategic mindset, and a collaborative spirit to deliver maximized titers and enhanced cell viability. We also conduct multi-sequence evaluations during the CLD stage to identify the best candidates with proven quality. Samsung Biologics provides a proprietary cell line, S-CHOice, as well as CHOZN, one of the most robust cell lines in the industry.

Single Cell Cloning with Beacon® & C.SIGHT™

  • Beacon® is a live cell-imaging and culture platform that enables high-throughput screening and advanced in-channel / in-pen assays to help scientists rapidly select relevant cells.
  • The C.SIGHT™ is a benchtop single-cell sorter that can rapidly isolate cells into multi-well plates. It has a gentle dispensing system, imaging platform, and intuitive software, making it a cost-efficient tool for various cell biology applications.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION